Heparan sulfate (HS) proteoglycans are commonly exploited by multiple viruses for initial attachment to host cells. Herpes simplex virus-1 (HSV-1) is unique because it can use HS for both attachment and penetration, provided specific binding sites for HSV-1 envelope glycoprotein gD are present. The interaction with gD is mediated by specific HS moieties or 3-O sulfated HS (3-OS HS), which are generated by all but one of the seven isoforms of 3-O sulfotransferases (3-OSTs). Here we demonstrate that several common experimental cell lines express unique sets of 3-OST isoforms. While the isoforms 3-OST-3, -5 and -6 were most commonly expressed, isoforms 3-OST-2 and -4 were undetectable in the cell lines examined. Since most cell lines expressed multiple 3-OST isoforms, we addressed the significance of 3-OS HS in HSV-1 entry by down-regulating 2-O-sulfation, a prerequisite for 3-OS HS formation, by knocking down 2-OST expression by RNA interference (RNAi). 2-OST knockdown was verified by reverse-transcriptase PCR and Western blot analysis, while 3-OS HS knockdown was verified by immunofluorescence. Cells showed a significant decrease in viral entry, suggesting an important role for 3-OS HS. Implicating 3-OS HS further, cells knocked down for 2-OST expression also demonstrated decreased cell-cell fusion when cocultivated with effector cells transfected with HSV-1 glycoproteins. Our findings suggest that 3-OS HS may play an important role in HSV-1 entry into many different cell lines. Copyright 2009 Elsevier Inc. All rights reserved.
pan class="Chemical">Heparan sulfate (pan class="Chemical">HS) proteoglycans are commonly exploited by multiple viruses for initial attachment to host cells. Herpes simplex virus-1 (HSV-1) is unique because it can use HS for both attachment and penetration, provided specific binding sites for HSV-1 envelope glycoprotein gD are present. The interaction with gD is mediated by specific HS moieties or 3-O sulfated HS (3-OS HS), which are generated by all but one of the seven isoforms of 3-O sulfotransferases (3-OSTs). Here we demonstrate that several common experimental cell lines express unique sets of 3-OST isoforms. While the isoforms 3-OST-3, -5 and -6 were most commonly expressed, isoforms 3-OST-2 and -4 were undetectable in the cell lines examined. Since most cell lines expressed multiple 3-OST isoforms, we addressed the significance of 3-OS HS in HSV-1 entry by down-regulating 2-O-sulfation, a prerequisite for 3-OS HS formation, by knocking down 2-OST expression by RNA interference (RNAi). 2-OST knockdown was verified by reverse-transcriptase PCR and Western blot analysis, while 3-OS HS knockdown was verified by immunofluorescence. Cells showed a significant decrease in viral entry, suggesting an important role for 3-OS HS. Implicating 3-OS HS further, cells knocked down for 2-OST expression also demonstrated decreased cell-cell fusion when cocultivated with effector cells transfected with HSV-1 glycoproteins. Our findings suggest that 3-OS HS may play an important role in HSV-1 entry into many different cell lines. Copyright 2009 Elsevier Inc. All rights reserved.
Authors: Gerdy B Ten Dam; Sindhulakshmi Kurup; Els M A van de Westerlo; Elly M M Versteeg; Ulf Lindahl; Dorothe Spillmann; Toin H van Kuppevelt Journal: J Biol Chem Date: 2005-12-22 Impact factor: 5.157
Authors: Vaibhav Tiwari; Christian Clement; Perry M Scanlan; Devanand Kowlessur; Beatrice Y J T Yue; Deepak Shukla Journal: J Virol Date: 2005-10 Impact factor: 5.103
Authors: Joann M Taylor; Erick Lin; Nanette Susmarski; Miri Yoon; Anna Zago; Carl F Ware; Klaus Pfeffer; Jun Miyoshi; Yoshimi Takai; Patricia G Spear Journal: Cell Host Microbe Date: 2007-07-12 Impact factor: 21.023
Authors: Christian Clement; Vaibhav Tiwari; Perry M Scanlan; Tibor Valyi-Nagy; Beatrice Y J T Yue; Deepak Shukla Journal: J Cell Biol Date: 2006-09-25 Impact factor: 10.539
Authors: Casey A Maguire; Leonora Balaj; Sarada Sivaraman; Matheus H W Crommentuijn; Maria Ericsson; Lucia Mincheva-Nilsson; Vladimir Baranov; Davide Gianni; Bakhos A Tannous; Miguel Sena-Esteves; Xandra O Breakefield; Johan Skog Journal: Mol Ther Date: 2012-02-07 Impact factor: 11.454